Strata Skin's Shares Plummet as Laseroptek Files Counterclaims for Unfair Business Practices

Strata Skin Sciences shares have plummeted 60% in pre-market trading after Laseroptek America filed counterclaims and third-party claims against the company and its CEO. Laseroptek alleges unfair competition, anticompetitive practices, and defamation. The counterclaims dispute reimbursement codes, product performance comparisons, and patent misrepresentations. Strata Skin markets XTRAC lasers, VTRAC lamp systems, and TheraClearX Acne Therapy System. The stock is currently trading at $0.46, down 61.61%.